Covered recipient · General Payments record
AJAY K SHUKLA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2024
$991.76
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $563.64 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $306.87 | 14 |
| PFIZER INC. | $74.07 | 4 |
| Lilly USA, LLC | $53.29 | 3 |
| CATALYST PHARMACEUTICALS, INC. | $46.02 | 2 |
| SCILEX PHARMACEUTICALS INC. | $24.15 | 1 |
| Novo Nordisk AS | $22.12 | 1 |
| Acerta Pharma LLC | $20.51 | 1 |
| Teva Pharmaceuticals USA, Inc. | $16.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.42 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094010 | CMS |
| ABBVIE INC. | $20.74 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094012 | CMS |
| ABBVIE INC. | $16.83 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094014 | CMS |
| ABBVIE INC. | $27.95 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094016 | CMS |
| ABBVIE INC. | $34.85 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094018 | CMS |
| ABBVIE INC. | $23.17 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094020 | CMS |
| ABBVIE INC. | $18.81 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094022 | CMS |
| ABBVIE INC. | $29.35 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094024 | CMS |
| ABBVIE INC. | $30.90 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094026 | CMS |
| ABBVIE INC. | $24.78 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094028 | CMS |
| ABBVIE INC. | $23.44 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094030 | CMS |
| ABBVIE INC. | $5.68 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094032 | CMS |
| ABBVIE INC. | $22.47 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094034 | CMS |
| ABBVIE INC. | $7.48 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106094036 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.51 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104261369 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $22.52 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144456104 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $23.50 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144456106 | CMS |
| Lilly USA, LLC | $18.85 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136013662 | CMS |
| Lilly USA, LLC | $14.80 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136012307 | CMS |
| Lilly USA, LLC | $19.64 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135995598 | CMS |
| Novo Nordisk Inc | $22.12 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096889830 | CMS |
| PFIZER INC. | $18.34 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131589098 | CMS |
| PFIZER INC. | $17.89 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131661696 | CMS |
| PFIZER INC. | $18.21 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132099585 | CMS |
| PFIZER INC. | $19.63 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131151004 | CMS |
| SCILEX PHARMACEUTICALS INC. | $24.15 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136272054 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.61 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151722472 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.